Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

L Yáñez, A Insunza, P Ibarrondo, C de Miguel,A Bermúdez,M Colorado,M López-Duarte,C Richard, E Conde

TRANSPLANT INFECTIOUS DISEASE（2015）

引用 4|浏览21

暂无评分

摘要

Our results are of interest owing to the absence of data in the literature on anidulafungin use in HSCT patients with GVHD, and suggest that anidulafungin, because of its spectrum, pharmacological profile, low toxicity, and absence of interactions with immunosuppressants, could be a drug of choice in this setting.

查看译文

关键词

anidulafungin,graft-versus-host disease,hematopoietic stem cell transplantation,invasive fungal disease,prophylaxis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要